SEC Form 4 · accession 0000899243-17-026272
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hugh M. O'Neill
Officer — Exec. VP & Pres, ARD
Period of report
Nov 14, 2017
Accepted (ET)
Nov 15, 2017 · 7:30 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Nov 14, 2017 | P | 9,000 | $21.80 | A | 40,297 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $21.78 to $21.80, inclusive. Mr. O'Neill will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.
- F2Includes 288 shares acquired between April 1, 2017 and September 30, 2017 under the Mallinckrodt employee stock purchase plan.